Details of Drug

Drug General Information (ID: D0332)
Drug Name	Chromium picolinate
Drug Type	Small molecule
Drug Synonymous	Chromium picolinate; 14639-25-9; Chromium(III) Picolinate; Chromium(III) Pyridine-2-carboxylate; chromiumpicolinate; chromium(3+);pyridine-2-carboxylate; 15713-60-7; UNII-S71T8B8Z6P; C18H12CrN3O6; Chromium (III) picolinate;Cr(Pic)3; CCRIS 8310; chromium(3+) tripyridine-2-carboxylate; 2-Pyridinecarboxylic acid, chromium salt; S71T8B8Z6P; MFCD00068715; Pyridine-2-carboxylic Acid Chromium(III) Salt; chromium tris-picolinate; DSSTox_CID_4831; Picolinic acid/chromium salt; DSSTox_RID_77546; DSSTox_GSID_24831; DTXSID1024831; BCP21370; Tox21_200574; BBL033863; chromium; pyridine-2-carboxylic acid; STL146656; AKOS005720870; AC-9849; DB11255; NCGC00248744-01; NCGC00258128-01; SY037125; CAS-14639-25-9; DB-042842; FT-0623788; P1347; A808500; J-008216; J-803060; Q2329715; CCRIS 8310; CCRIS-8310; CCRIS8310; Chromax; chromium; pyridine-2-carboxylic acid;Chromium picolinate Click to Show/Hide
Therapeutic Class	Minerals And Electrolytes
Structure
Structure	3D Structure		2D Structure
Formula	C18H12CrN3O6
InChI	InChI=1S/3C6H5NO2.Cr/c38-6(9)5-3-1-2-4-7-5;/h31-4H,(H,8,9);/q;;;+3/p-3
InChIKey	CBDQOLKNTOMMTL-UHFFFAOYSA-K
Canonical SMILES	C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].[Cr+3]
External Link
External Link	Pubchem ID	151932

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM006 Pharmacodynamic additive effects BM003 Complex formation BM064 Increased risk of hypoglycemia
Relation Graph

Full list of drugs interacting with Chromium picolinate
Affected gastrointestinal absorption
	Complex formation					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[4], [5], [6]
D0144		Baloxavir marboxil	C27H23F2N3O7S	124081896	Moderate		Inter Info	[7]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0433		Deferiprone	C7H9NO2	2972	Moderate		Inter Info	[40]
D0561		Eltrombopag	C25H22N4O4	135449332	Moderate		Inter Info	[41], [42]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[5], [43], [6]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[44], [45], [4], [5], [46], [6]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D1245		Penicillamine	C5H11NO2S	5852	Moderate		Inter Info	[47], [48], [49], [50], [51], [52], [53], [29]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[4], [5], [6]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Moderate		Inter Info	[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
Pharmacodynamic additive effects
	Increased risk of hypoglycemia					Drug Num: 36
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[1], [2], [3]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[1], [2], [3]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[1], [2], [3]
D1782		Ertugliflozin	C22H25ClO7	44814423	Moderate		Inter Info	[1], [2], [3]
D1887		Semaglutide	C187H291N45O59	56843331	Moderate		Inter Info	[1], [2], [3]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[1], [2], [3]
D1779		Dulaglutide	NA	NA	Moderate		Inter Info	[1], [2], [3]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[1], [2], [3]
D1784		Exenatide	C184H282N50O60S	45588096	Moderate		Inter Info	[1], [2], [3]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[1], [2], [3]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[1], [2], [3]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[1], [2], [3]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[1], [2], [3]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[1], [2], [3]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[1], [2], [3]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[1], [2], [3]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[1], [2], [3]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[1], [2], [3]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[1], [2], [3]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[1], [2], [3]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[1], [2], [3]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[1], [2], [3]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[1], [2], [3]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[1], [2], [3]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[1], [2], [3]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[1], [2], [3]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[1], [2], [3]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[1], [2], [3]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[1], [2], [3]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[1], [2], [3]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[1], [2], [3]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[1], [2], [3]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[1], [2], [3]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[1], [2], [3]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[1], [2], [3]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[1], [2], [3]

References
1	Anderson RA, cheng N, Bryden NA, et al "Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes." Diabetes 46 (1997): 1786-91. [PMID: 9356027]
2	Martin J, Wang ZQ, Zhang XH, et al. "Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes." Diabetes Care 29 (2006): 1826-32. [PMID: 16873787]
3	Fox GN, Sabovic Z "Chromium picolinate supplementation for diabetes mellitus." J Fam Pract 46 (1998): 83-6. [PMID: 9451374]
4	Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
5	Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
6	Product Information. Skelid (tilundronate). Sanofi Winthrop Pharmaceuticals, New York, NY.
7	Product Information. Xofluza (baloxavir marboxil). Genentech, South San Francisco, CA.
8	Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
9	Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
10	Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
11	Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
12	Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
13	Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
14	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
15	Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
16	Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
17	Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
18	Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
19	Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
20	Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
21	Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
22	Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
23	Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
24	Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
25	Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
26	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
27	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
28	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
29	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
30	Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
31	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
32	Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
33	Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
34	Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
35	Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
36	Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
37	Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
38	Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
39	Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
40	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
41	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
42	Product Information. Promacta (eltrombopag). GlaxoSmithKline, Research Triangle Park, NC.
43	Product Information. Fosamax (alendronate). Merck &amp Co, Inc, West Point, PA.
44	Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
45	Product Information. Actonel (risedronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
46	Product Information. Fosamax (alendronate). Merck & Co, Inc, West Point, PA.
47	Haagsma CJ "Clinically important drug interactions with disease-modifying antirheumatic drugs." Drugs Aging 13 (1998): 281-9. [PMID: 9805209]
48	Harkness JA, Blake DR "Penicillamine nephropathy and iron." Lancet 2 (1982): 1368-9. [PMID: 6129465]
49	Joyce DA "D-penicillamine pharmacokinetics and pharmacodynamics in man." Pharmacol Ther 42 (1989): 405-27. [PMID: 2672052]
50	Lyle WH "Penicillamine and iron." Lancet 2 (1976): 420. [PMID: 73880]
51	Netter P, Bannwarth B, Pere P, Nicolas A "Clinical pharmacokinetics of D-penicillamine." Clin Pharmacokinet 13 (1987): 317-33. [PMID: 3319347]
52	Osman MA, Patel RB, Schuna A, Sundstrom WR, Welling PG "Reduction in oral penicillamine absorption by food, antacid and ferrous sulfate." Clin Pharmacol Ther 33 (1983): 465-70. [PMID: 6831825]
53	Product Information. Cuprimine (penicillamine). Merck & Co, Inc, West Point, PA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence